Abstract
This study was undertaken to assess the future of the pharmaceutical industry in Bangladesh under the
WTO regime. The study indicates that if Bangladesh fails to formulate strategies both at the macro and
micro levels by the year 2016, it will lose its competitive edge that it has been maintaining in this region
since 1982.